Cargando...
Large Scale Identification of Variant Proteins in Glioma Stem Cells
Glioblastoma (GBM), the most malignant of primary brain tumors, is a devastating and deadly disease, with a median survival of 14 months from diagnosis, despite standard regimens of radical brain tumor surgery, maximal safe radiation, and concomitant chemotherapy. GBM tumors nearly always re-emerge...
Guardado en:
| Publicado en: | ACS Chem Neurosci |
|---|---|
| Autores principales: | , , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6008157/ https://ncbi.nlm.nih.gov/pubmed/29254333 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acschemneuro.7b00362 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|